Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	30.95	20.01	22.99	19.36	49.65
Cash & Short-Term Investments	30.95	20.01	22.99	19.36	49.65
Cash Growth	54.71%	-12.96%	18.72%	-61.01%	3.26%
Receivables	31.16	23.53	28.73	21.71	28.18
Inventory	11.43	12.14	8.51	10.85	16.34
Prepaid Expenses	5.64	5.1	5.43	7.38	9.78
Restricted Cash	-	-	-	-	0.25
Other Current Assets	-	1.12	5.43	0.63	1.04
Total Current Assets	79.18	61.89	71.08	59.93	105.23
Property, Plant & Equipment	1.59	1.52	3.61	6.3	8.7
Goodwill	-	-	-	-	65.8
Other Intangible Assets	42.2	52.45	57.44	70.63	85.46
Long-Term Deferred Tax Assets	0.25	0.76	1.38	-	-
Other Long-Term Assets	0.95	1.47	2.96	0.77	0.47
Total Assets	124.18	118.1	136.46	137.62	265.67
Accounts Payable	10.6	10.31	12.55	10.99	19.26
Accrued Expenses	15.26	22.26	24.54	25.71	30.72
Short-Term Debt	9.06	2.4	1.56	3.81	7.93
Current Portion of Long-Term Debt	1.86	1.86	-	-	16.57
Current Portion of Leases	0.14	0.71	1.34	0.1	0.1
Other Current Liabilities	26.15	24.69	29.02	23.84	34.86
Total Current Liabilities	63.06	62.23	69.02	64.44	109.44
Long-Term Debt	10.9	10.88	14.71	14.2	-
Long-Term Leases	0.99	0.58	0.83	0.08	0.18
Long-Term Deferred Tax Liabilities	0.25	0.76	1.38	-	-
Other Long-Term Liabilities	30.02	15.94	11.17	14.59	18.48
Total Liabilities	105.21	90.38	97.11	93.32	128.1
Common Stock	0	0	0	-	0
Additional Paid-In Capital	352.5	347.69	343.49	331.39	315.86
Retained Earnings	-333.54	-319.97	-304.13	-287.08	-178.3
Total Common Equity	18.97	27.72	39.36	44.31	137.57
Shareholders' Equity	18.97	27.72	39.36	44.31	137.57
Total Liabilities & Equity	124.18	118.1	136.46	137.62	265.67
Total Debt	22.94	16.42	18.45	18.19	24.78
Net Cash (Debt)	8.02	3.59	4.53	1.17	24.87
Net Cash Growth	123.38%	-20.87%	286.86%	-95.29%	-46.03%
Net Cash Per Share	1.28	0.65	1.36	0.80	29.70
Filing Date Shares Outstanding	9.91	6.17	5.53	3.12	1.38
Total Common Shares Outstanding	8.98	5.97	5.52	1.93	1.37
Working Capital	16.12	-0.34	2.06	-4.51	-4.2
Book Value Per Share	2.11	4.64	7.13	22.97	100.08
Tangible Book Value	-23.24	-24.74	-18.08	-26.32	-13.7
Tangible Book Value Per Share	-2.59	-4.14	-3.28	-13.65	-9.97
Machinery	1.08	2.78	4.29	4.45	5
Construction In Progress	-	-	0.11	-	0.2
Leasehold Improvements	0.16	0.04	1	1	0.96

Updated Sep 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q